Gibco™ KaryoMAX™ Colcemid™ Solution in HBSS is a 10 μg/mL N-desacetyl-N-methylocolchicine (Colcemid™) solution made up in Hanks' Balanced Salt Solution (HBSS). Colcemid™ prevents spindle formation during mitosis, arresting cells in metaphase so that the chromosomes can be separated for cytogenetic studies and in vitro diagnostic procedures. The mechanism of action is similar to that of colchicine, but with lower mammalian toxicity.

The complete formulation is available.

cGMP Manufacturing and Quality System
Gibco™ KaryoMAX™ Colcemid™ Solution in HBSS is manufactured at a cGMP compliant facility, located in Grand Island, New York. The facility is registered with the FDA as a medical device manufacturer and is certified to ISO 13485 standards.